Clearance of mutant huntingtin

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Huntington's disease (HD) is characterized by neuronal cell death caused by mutant huntingtin (htt) protein with an expanded polyglutamine (polyQ) repeat.
• The accumulation of toxic N-terminal mutant htt fragments is linked to HD pathogenesis and neurological deficits.
• Both the ubiquitin-proteasomal system (UPS) and autophagy are involved in clearing mutant htt, but their relative efficiencies are not well understood.

Purpose of the Study:

• To compare the efficiency of the ubiquitin-proteasomal system (UPS) versus autophagy in clearing toxic mutant huntingtin (htt) fragments in cellular and mouse models of Huntington's disease (HD).

Main Methods:

• Utilized cellular and transgenic mouse models of Huntington's disease (HD).
• Inhibited the ubiquitin-proteasomal system (UPS) and autophagy pathways independently.
• Quantified the accumulation of N-terminal mutant huntingtin (htt) fragments and full-length mutant htt.

Main Results:

• Inhibition of the UPS resulted in significantly greater accumulation of mutant huntingtin (htt) compared to the inhibition of autophagy.
• N-terminal mutant htt fragments, but not full-length mutant htt, accumulated in the brains of HD mice when the UPS was inhibited.
• These findings indicate differential clearance mechanisms for different forms of mutant htt.

Conclusions:

• The ubiquitin-proteasomal system (UPS) is more efficient than autophagy in clearing toxic N-terminal mutant huntingtin (htt) fragments associated with Huntington's disease (HD).
• Targeting the UPS may represent a therapeutic strategy for enhancing the clearance of specific toxic htt species in HD.
• Understanding the distinct roles of cellular clearance pathways is crucial for developing effective HD treatments.